Blackstone plots $4.5B+ life sciences fund — and they've already secured the bulk of it
More than a year ago Blackstone jumped into the deep end of life sciences investing by buying Clarus, a storied investor in the field with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
